Incentive plan linked to research in work for the pharmaceutical industry
The details of the RLI scheme are not yet specified, but to be eligible for the incentives, companies may be asked to invest at least 15% of their turnover in R&D.
pharmaceutical companies | biocon | Coronavirus vaccine
Sohini Das |
Last Updated Jul 3, 2022 1:28 PM IST
The Center may announce a Research Linked Incentive (RLI) program for the pharmaceutical industry to increase contribution to research and development (R&D) and move up the innovation value chain, it said. sources close to the development.
TO READ THE FULL STORY, SUBSCRIBE NOW FOR JUST RS 249 PER MONTH.
Key stories on business-standard.com are only available to premium subscribers.
Already a premium subscriber? LOGIN NOW
SUBSCRIBE TO PERSPECTIVES
What do you get on Business Standard Premium?
First published: Sun 03 Jul 2022. 13:28 IST